EP2641601
Aðferð við meðhöndlun á fjölmergæxli með því að nota samsettar meðferðir byggðar á HuLuc63 með bortesómib
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.8.2007EP published:
6.7.2016EP application number:
13168383.1
EP translation filed:
19.8.2016Grant published:
15.9.2016EPO information:
European Patent Register
Max expiry date:
6.8.2027Expiry date:
6.8.2026Next due date:
31.8.2026
Title:
Methods of treating multiple myeloma using combination therapies based on HuLuc63 with bortezomib
Timeline
Today
7.8.2007EP application
6.7.2016EP Publication
19.8.2016Translation submitted
15.9.2016Registration published
6.8.2026Expires
Owner
Name:
AbbVie Biotherapeutics Inc.Address:
1500 Seaport Boulevard, 94063, Redwood City, CA, US
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02215, Boston, MA, US
Inventor
Name:
Afar, DanielAddress:
Fremont, California, US
Name:
Andersen, Kenneth C.Address:
Wellesley, Massachusetts, US
Name:
Tai, Yu-TzuAddress:
Newton, Massachusetts, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
836185 PDate:
7.8.2006Country:
US
Number:
944262 PDate:
15.6.2007Country:
US
Classification
Categories:
A61K 31/573, A61K 31/454, A61K 31/69, A61K 39/395, A61P 35/00, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 8.8.2016
Expires: 6.8.2017
Payer: Örn Þór, slf.
Number: 11
Paid: 14.7.2017
Expires: 6.8.2018
Payer: Örn Þór, slf.
Number: 12
Paid: 17.7.2018
Expires: 6.8.2019
Payer: Örn Þór, slf.
Number: 13
Paid: 15.7.2019
Expires: 6.8.2020
Payer: Örn Þór, slf.
Number: 14
Paid: 10.7.2020
Expires: 6.8.2021
Payer: Örn Þór slf.
Number: 15
Paid: 13.7.2021
Expires: 6.8.2022
Payer: Örn Þór slf.
Number: 16
Paid: 12.7.2022
Expires: 6.8.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 21.6.2023
Expires: 6.8.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 23.7.2024
Expires: 6.8.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 7.8.2025
Expires: 6.8.2026
Payer: Árnason Faktor ehf.